Trial · NCT02569827
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
NCT02569827, Phase 1, Phase 2, Withdrawn, Singapore General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore. Trials, record NCT02569827. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02569827
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
- NCT number
- NCT02569827
- Status
- Withdrawn
- Phases
- Phase 1, Phase 2
- Enrollment
- 0 participants, actual
- Lead sponsor
- Singapore General Hospital
- Conditions
- Dengue Fever
- Interventions
- Celgosivir, Modipafant 50mg, Placebo, Modipafant 100mg
- First posted
- 2015-10-07
- Last updated
- 2020-03-23
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Viral load AUC for viremia | Day 1 to Day 5 | Area under the curve (AUC) for serum viral load from baseline to Study Day 5 of Celgosivir dosing |
| Primary | Platelet nadir | Day 1 to Day 5 | Lowest platelet count recorded from baseline to Study Day 5 of Modipafant dosing |
| Secondary | Fever clearance time (days) | Day 1 to 28 | The time from the start of treatment to the start of the first 24-hour period during which the tympanic or oral temperature remains below 37.5°C |
| Secondary | Duration of illness | Day 1 to 28 | A 24-hour reduction in duration of illness that is treatment related is deemed clinically relevant. Draft criteria to support this include: Absence of fever (\< 37.4˚C) for at least 24 hours |
| Secondary | Maximum percentage haemoconcentration | Day 1 to 28 | Determined by comparison of the maximum haematocrit detected in the acute phase as compared to baseline |
| Secondary | Time to NS1 clearance | Day 1 to 28 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02569827
GET https://conductscience.org/api/trials/v1/NCT02569827/registered